Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H ( ($HK:6990) ) has provided an update. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Bankrupt DNA testing company 23andMe was purchased Monday by biotechnology company Regeneron for $256 million. Both companies ...

The Biotechnology Program has also expanded its STEM outreach efforts to include a summer internship program for high school ...

With one of the most densely concentrated life sciences hubs in Europe, the Netherlands sets its sights on becoming a global ...

In its announcement of the acquisition, Regeron claimed it would ensure that customers’ personal data including genetic and ...

Krystal Biotech ( ($KRYS) ) has issued an announcement. On May 16, 2025, Krystal Biotech held its Annual Meeting of Stockholders where key ...

On May 16, 2024, the CDE’s official website announced that the Application would be reviewed via the priority review and approval process. This marks the fourth sac-TMT indication to go through the ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

The discovery of recombinant DNA proved that biology, not chemistry alone, could create new medicines like life-saving ...

Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...